Selskabets formål er at drive handel og produktion
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 26.9 mio. | 583 t. | 35.1 mio. | 2.1 mio. | 42 | |
CVR: 16279099
Secondary names: SCANZYM A/S, SCANDRUG A/S, PHARMANOVA A/S
Previous names: A/S PSE NR. 4681, A/S SCANPHARM AF 1992, SCANPHARM A/S AF 1992
Compared to 130 companies in Fremstilling af farmaceutiske præparater
Comparison is based on industry median values
Andreas Bjørn Jensen joined the board
Ole Bjørn Jensen left the board
Companies in the same industry and area
CVR 37007617
CVR 31603390
CVR 34459975
CVR 35419543
CVR 43730967